1 / 4

Tuberculosis (TB) Therapeutics Market Share, Trends, Size, Research and Forecast 2019-2025

Global tuberculosis (TB) therapeutics market is anticipated to grow at a significant CAGR of over 4% during the forecast period. Government initiatives for promoting education about tuberculosis diagnosis and treatment among the population will drive the market growth. Multiple partnerships with government and non-government organizations have been the major key strategy adopted by market players globally.

shriram01
Télécharger la présentation

Tuberculosis (TB) Therapeutics Market Share, Trends, Size, Research and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Tuberculosis (TB) Therapeutics Market Share, Trends, Size, Research and Forecast 2019-2025 Request a free sample of our report on https://www.omrglobal.com/request-sample/tuberculosis-tb-therapeutics-market Tuberculosis (TB) Therapeutics Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. Global tuberculosis (TB) therapeutics market is anticipated to grow at a significant CAGR of over 4% during the forecast period. Government initiatives for promoting education about tuberculosis diagnosis and treatment among the population will drive the market growth. Multiple partnerships with government and non-government organizations have been the major key strategy adopted by market players globally. These collaborations have been aiming for eliminating tuberculosis from society by supplying an adequate number of drugs to several countries as well as government organizations. Moreover, increasing spending on R&D for the development of new drugs tend to drive the growth of global tuberculosis (TB) therapeutics market during the forecast period. Funding for research and development in the field of tuberculosis treatment will offer a huge opportunity for the global tuberculosis therapeutics industry across the globe. Funding for R&D has been increasing significantly over past levels, and other institutional barriers to research and development have been resolved. A https://www.omrglobal.com/industry-reports/tuberculosis-tb-therapeutics-market full report of Global Tuberculosis (TB) Therapeutics Market is available at: In 2017, Funding for TB care and prevention reached $6.9 billion in 118 low and middle-income countries. Funding on research and developments in 2016 was $6.3 billion and it was more than double the funding in 2006 which was approximately $3.3 billion. Such an increase in funding on tuberculosis tends to provide ample opportunity for the growth of global tuberculosis (TB) therapeutics market in the near future. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/tuberculosis-tb-therapeutics-market Johnson and Johnson Services Inc., Lupin Ltd., Otsuka Pharmaceutical Co. Ltd., Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Novartis International AG, and Pfizer Inc are some of the key players operating in global tuberculosis (TB) therapeutics industry. The players are collaborating with non-profit organizations to meet the needs of the people. For instance, in 2019., Macleods Pharmaceuticals Ltd. collaborated with TB Alliance for a new therapy for highly drug-resistant TB. Macleods Pharmaceuticals was granted a non-exclusive license by TB Alliance to manufacture the anti- TB drug pretomanid as part of the three-drug “BPaL” regimen. Such collaborations tend to expand global tuberculosis (TB) therapeutics market size in the near future.

  3. Global Tuberculosis (TB) Therapeutics Market Segmentation By Disease Type Active TB Latent TB By Therapy First-Line Therapy Second-Line Therapy For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/tuberculosis-tb-therapeutics-market Global Tuberculosis (TB) Therapeutics Market – Segmentation by Region North America United States Canada Europe Germany United Kingdom France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific

  4. Rest of the World Middle East & Africa Latin America Company Profiles Akorn Inc. AstraZeneca Plc Biochemical and Synthetic Products Pvt Ltd. Eli Lilly & Co. GlaxoSmithKline Plc Johnson and Johnson Services Inc. LabatecPharma SA Lupin Ltd. Macleods Pharmaceuticals Ltd. Merck& Co. Inc. Mylan N.V. Novartis International AG Otsuka Pharmaceutical Co. Ltd. Pfizer Inc. Sanofi SA About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related